ENTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.64%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $306,026.21

Enanta Pharmaceuticals Insider Trading History Chart

Enanta Pharmaceuticals Share Price & Price History

^$6.28

▲ +0.42 (7.17%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Enanta Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/6/2024	Jay R. Luly	CEO	Sell	5,142	$8.06	$41,444.52	801,638
12/6/2024	Tara Lynn Kieffer	Insider	Sell	2,283	$8.06	$18,400.98	29,305
7/15/2024	Scott T Rottinghaus	Insider	Sell	5,375	$17.08	$91,805.00	21,717
7/11/2024	Scott T Rottinghaus	Insider	Sell	4,299	$15.07	$64,785.93	23,988
6/17/2024	Tara Lynn Kieffer	Insider	Sell	7,266	$12.33	$89,589.78	32,341
12/13/2023	Terry Vance	Director	Sell	15,295	$9.12	$139,490.40	5,800
12/5/2023	Brendan Luu	VP	Sell	2,125	$9.63	$20,463.75	36,736
12/5/2023	Jay R. Luly	CEO	Sell	7,230	$9.63	$69,624.90	806,793
12/5/2023	Paul J Mellett	CFO	Sell	2,412	$9.63	$23,227.56	93,549
12/5/2023	Scott T Rottinghaus	CMO	Sell	534	$9.63	$5,142.42	26,466
3/15/2023	Paul J Mellett	CFO	Sell	10,440	$44.43	$463,849.20	97,556
3/15/2023	Yat Sun Or	VP	Sell	13,925	$44.45	$618,966.25	374,702
3/13/2023	Jay R. Luly	CEO	Sell	27,912	$45.16	$1,260,505.92	819,810
2/9/2023	Paul J Mellett	CFO	Sell	5,000	$53.76	$268,800.00	83,463
12/16/2022	Jay R. Luly	CEO	Sell	30,000	$44.72	$1,341,600.00	773,805
4/4/2022	Nathalie Adda	VP	Sell	32,785	$72.18	$2,366,421.30	34,982
4/1/2022	Nathalie Adda	VP	Sell	50,559	$71.23	$3,601,317.57	34,982
3/21/2022	Bruce L A Carter	Director	Sell	6,000	$67.83	$406,980.00
3/1/2022	Nathalie Adda	VP	Sell	24,339	$70.26	$1,710,058.14
1/11/2022	Nathalie Adda	VP	Sell	12,536	$70.13	$879,149.68

The #1 Coin for November 2024

From Crypto 101 Media | Ad

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

SEC Filings (Institutional Ownership Changes) for Enanta Pharmaceuticals (NASDAQ:ENTA)

94.99% of Enanta Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	27,438	$0.29M	0.0%	+294.2%	0.129%
11/16/2024	Geode Capital Management LLC	477,351	$4.95M	0.0%	+3.1%	2.253%
11/15/2024	Barclays PLC	27,438	$0.29M	0.0%	+294.2%	0.129%
11/15/2024	Krensavage Asset Management LLC	1,498,074	$15.52M	8.7%	+19.7%	7.070%
11/15/2024	Jane Street Group LLC	23,176	$0.24M	0.0%	-19.2%	0.109%
11/15/2024	Wellington Management Group LLP	34,751	$0.36M	0.0%	N/A	0.164%
11/15/2024	State Street Corp	449,975	$4.66M	0.0%	+6.4%	2.124%
11/15/2024	Point72 Asset Management L.P.	87,190	$0.90M	0.0%	N/A	0.411%
11/15/2024	Jacobs Levy Equity Management Inc.	191,726	$1.99M	0.0%	-1.5%	0.905%
11/15/2024	Erste Asset Management GmbH	120,000	$1.24M	0.0%	N/A	0.566%
11/14/2024	Caligan Partners LP	322,453	$3.34M	1.1%	-69.1%	1.522%
11/14/2024	PDT Partners LLC	33,342	$0.35M	0.0%	-8.0%	0.157%
11/14/2024	Walleye Capital LLC	43,899	$0.46M	0.0%	+96.4%	0.207%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	170,615	$1.77M	0.0%	-13.9%	0.805%
11/13/2024	FMR LLC	49,301	$0.51M	0.0%	+18.9%	0.233%
11/12/2024	Valence8 US LP	19,939	$0.21M	0.1%	N/A	0.094%
11/12/2024	Charles Schwab Investment Management Inc.	162,398	$1.68M	0.0%	-1.0%	0.766%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	11,768	$0.12M	0.0%	N/A	0.056%
11/7/2024	Quest Partners LLC	19,123	$0.20M	0.0%	+65.0%	0.090%
10/28/2024	US Bancorp DE	4,329	$45K	0.0%	+4,933.7%	0.020%
10/23/2024	Assenagon Asset Management S.A.	143,806	$1.49M	0.0%	-66.3%	0.679%
9/16/2024	Cubist Systematic Strategies LLC	45,350	$0.59M	0.0%	+65.8%	0.214%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	14,326	$0.19M	0.0%	-43.2%	0.068%
8/15/2024	Millennium Management LLC	683,143	$8.86M	0.0%	-3.3%	3.226%
8/15/2024	AQR Capital Management LLC	60,005	$0.78M	0.0%	-45.3%	0.283%
8/15/2024	Armistice Capital LLC	1,096,000	$14.22M	0.2%	-11.3%	5.175%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	14,326	$0.19M	0.0%	-43.2%	0.068%
8/14/2024	Cubist Systematic Strategies LLC	45,350	$0.59M	0.0%	+65.8%	0.214%
8/14/2024	Marshall Wace LLP	928,363	$12.04M	0.0%	-2.4%	4.383%
8/13/2024	Sei Investments Co.	72,925	$0.95M	0.0%	-17.3%	0.344%
8/12/2024	Hsbc Holdings PLC	18,086	$0.23M	0.0%	-11.3%	0.085%
8/9/2024	Renaissance Technologies LLC	510,900	$6.63M	0.0%	-2.9%	2.412%
8/9/2024	Dimensional Fund Advisors LP	129,062	$1.67M	0.0%	-31.8%	0.609%
8/8/2024	American Century Companies Inc.	27,892	$0.36M	0.0%	+35.4%	0.132%
8/6/2024	Quest Partners LLC	11,588	$0.15M	0.0%	+511.2%	0.055%
8/6/2024	Acadian Asset Management LLC	849,424	$11.01M	0.0%	-0.5%	4.011%
8/1/2024	Rhumbline Advisers	34,566	$0.45M	0.0%	+4.7%	0.163%
7/26/2024	Allspring Global Investments Holdings LLC	2,667	$35K	0.0%	N/A	0.013%
7/26/2024	Bank of New York Mellon Corp	73,841	$0.96M	0.0%	+13.3%	0.349%
7/18/2024	Assenagon Asset Management S.A.	426,561	$5.53M	0.0%	-26.9%	2.014%
5/24/2024	Farallon Capital Management LLC	2,095,000	$36.58M	0.2%	+3.5%	9.891%
5/20/2024	Virtu Financial LLC	10,927	$0.19M	0.0%	N/A	0.052%
5/16/2024	California State Teachers Retirement System	2,037	$36K	0.0%	-38.1%	0.010%
5/16/2024	Jacobs Levy Equity Management Inc.	194,730	$3.40M	0.0%	-65.3%	0.919%
5/15/2024	Public Employees Retirement System of Ohio	7,662	$0.13M	0.0%	-76.3%	0.036%
5/10/2024	Acadian Asset Management LLC	853,896	$14.91M	0.1%	+1.3%	4.036%
5/10/2024	Vanguard Group Inc.	1,928,078	$33.66M	0.0%	+7.5%	9.114%
5/9/2024	State Board of Administration of Florida Retirement System	6,781	$0.12M	0.0%	N/A	0.032%
5/9/2024	Portland Global Advisors LLC	24,375	$0.43M	0.1%	-28.7%	0.115%
5/8/2024	Russell Investments Group Ltd.	19,213	$0.34M	0.0%	-19.9%	0.091%
5/7/2024	SG Americas Securities LLC	7,574	$0.13M	0.0%	-25.5%	0.036%
5/1/2024	BNP Paribas Financial Markets	24,683	$0.43M	0.0%	-50.1%	0.117%
4/17/2024	Hennion & Walsh Asset Management Inc.	13,689	$0.24M	0.0%	-13.1%	0.065%
2/14/2024	Pennant Investors LP	35,100	$0.33M	0.1%	N/A	0.166%
2/13/2024	Armistice Capital LLC	2,064,000	$19.42M	0.3%	-1.7%	9.754%
2/9/2024	Quest Partners LLC	15,465	$0.15M	0.0%	N/A	0.073%
2/9/2024	Trexquant Investment LP	118,612	$1.12M	0.0%	-10.5%	0.561%
2/7/2024	Jump Financial LLC	31,868	$0.30M	0.0%	-43.7%	0.151%
2/7/2024	BNP Paribas Financial Markets	49,459	$0.47M	0.0%	-10.8%	0.234%
2/1/2024	New York State Common Retirement Fund	7,772	$73K	0.0%	-23.1%	0.037%
1/31/2024	Federated Hermes Inc.	133,189	$1.25M	0.0%	N/A	0.629%
1/30/2024	Strs Ohio	18,700	$0.18M	0.0%	+20.6%	0.089%
1/25/2024	Nisa Investment Advisors LLC	2,827	$27K	0.0%	+417.8%	0.013%
1/17/2024	Assenagon Asset Management S.A.	583,658	$5.49M	0.0%	-7.6%	2.771%
1/12/2024	SG Americas Securities LLC	10,162	$96K	0.0%	-45.2%	0.048%
1/8/2024	Diversified Trust Co	16,900	$0.16M	0.0%	N/A	0.080%
12/18/2023	Vanguard Group Inc.	1,660,520	$18.55M	0.0%	-2.7%	7.885%
11/21/2023	Walleye Capital LLC	119,364	$1.33M	0.0%	+342.8%	0.567%
11/17/2023	Jacobs Levy Equity Management Inc.	345,651	$3.86M	0.0%	-0.5%	1.641%
11/15/2023	Krensavage Asset Management LLC	735,103	$8.21M	3.0%	+6.9%	3.491%
11/15/2023	Laurion Capital Management LP	11,287	$0.13M	0.0%	N/A	0.054%
11/15/2023	Armistice Capital LLC	2,100,000	$23.46M	0.4%	+3.1%	9.972%
11/14/2023	Caxton Associates LP	18,028	$0.20M	0.0%	N/A	0.086%
11/14/2023	Sherbrooke Park Advisers LLC	10,100	$0.11M	0.0%	N/A	0.048%
11/14/2023	Trexquant Investment LP	132,561	$1.48M	0.0%	N/A	0.629%
11/13/2023	Acadian Asset Management LLC	548,782	$6.13M	0.0%	+445.6%	2.606%
11/13/2023	Clearstead Advisors LLC	5,064	$57K	0.0%	N/A	0.024%
11/8/2023	Janney Montgomery Scott LLC	62,452	$0.70M	0.0%	N/A	0.297%
11/7/2023	Virtus ETF Advisers LLC	12,784	$0.14M	0.1%	-11.5%	0.061%
11/7/2023	Quantbot Technologies LP	7,200	$80K	0.0%	+2,300.0%	0.034%
11/7/2023	Clearstead Advisors LLC	5,064	$57K	0.0%	N/A	0.024%
11/7/2023	Barclays PLC	17,219	$0.19M	0.0%	-66.2%	0.082%
11/7/2023	Jump Financial LLC	56,636	$0.63M	0.0%	+41.5%	0.269%
11/6/2023	Assenagon Asset Management S.A.	631,626	$7.06M	0.0%	+613.6%	2.999%
10/27/2023	Hennion & Walsh Asset Management Inc.	28,034	$0.31M	0.0%	-7.8%	0.133%
10/24/2023	Bank of New York Mellon Corp	107,955	$1.21M	0.0%	-34.9%	0.513%
10/13/2023	SG Americas Securities LLC	18,546	$0.21M	0.0%	-68.9%	0.088%
10/10/2023	Daymark Wealth Partners LLC	10,000	$0.11M	0.0%	N/A	0.047%
9/21/2023	Barclays PLC	50,904	$1.09M	0.0%	+93.9%	0.242%
8/11/2023	Krensavage Asset Management LLC	687,613	$14.72M	4.7%	+14.0%	3.265%
8/10/2023	Profund Advisors LLC	17,594	$0.38M	0.0%	+65.9%	0.084%
8/9/2023	BNP Paribas Arbitrage SNC	46,853	$1M	0.0%	+102.3%	0.222%
8/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	22,372	$0.48M	0.0%	+7.6%	0.106%
8/8/2023	Rhumbline Advisers	64,744	$1.39M	0.0%	+1.4%	0.307%
8/7/2023	Principal Financial Group Inc.	115,487	$2.47M	0.0%	-5.0%	0.548%
8/7/2023	Acadian Asset Management LLC	100,581	$2.15M	0.0%	N/A	0.478%
8/3/2023	Barclays PLC	50,904	$1.09M	0.0%	+93.9%	0.242%
8/3/2023	Bank of New York Mellon Corp	165,793	$3.55M	0.0%	-1.1%	0.787%
7/31/2023	Strs Ohio	15,500	$0.33M	0.0%	+8.4%	0.074%
7/31/2023	Inspire Investing LLC	14,743	$0.32M	0.0%	+118.4%	0.070%

Data available starting January 2016

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $6.28

$5.72

$6.31

50 Day Range

MA: $9.73

$5.85

$13.00

52 Week Range

Now: $6.28

$5.70

$17.80

Volume

650,860 shs

Average Volume

224,591 shs

Market Capitalization

$133.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top insider shareholders include:
Jay R Luly (CEO)
Yat Sun Or (VP)
Paul J Mellett (CFO)
Brendan Luu (VP)
Tara Lynn Kieffer (Insider)
Scott T Rottinghaus (CMO)
Scott T Rottinghaus (Insider)
Terry Vance (Director)
Learn More about top insider investors at Enanta Pharmaceuticals.
Who are the major institutional investors of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top institutional investors include:
Krensavage Asset Management LLC — 7.07%
Geode Capital Management LLC — 2.25%
State Street Corp — 2.12%
Caligan Partners LP — 1.52%
Jacobs Levy Equity Management Inc. — 0.90%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.81%
Learn More about top institutional investors of Enanta Pharmaceuticals stock.
Which major investors are selling Enanta Pharmaceuticals stock?: During the last quarter, ENTA stock was sold by these institutional investors:
Caligan Partners LP
Assenagon Asset Management S.A.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Jane Street Group LLC
PDT Partners LLC
Jacobs Levy Equity Management Inc.
Charles Schwab Investment Management Inc.
In the last year, company insiders that have sold Enanta Pharmaceuticals company stock include:
Jay R Luly (CEO)
Yat Sun Or (VP)
Paul J Mellett (CFO)
Learn More investors selling Enanta Pharmaceuticals stock.
Which major investors are buying Enanta Pharmaceuticals stock?: During the previous quarter, ENTA stock was bought by institutional investors including:
Krensavage Asset Management LLC
Erste Asset Management GmbH
Point72 Asset Management L.P.
Wellington Management Group LLP
State Street Corp
Walleye Capital LLC
Barclays PLC
Barclays PLC